Literature DB >> 21499086

Impact of previous antibiotic therapy on outcome of Gram-negative severe sepsis.

Michael T Johnson1, Richard Reichley, Joan Hoppe-Bauer, W Michael Dunne, Scott Micek, Marin Kollef.   

Abstract

OBJECTIVE: To determine whether exposure to antimicrobial agents in the previous 90 days resulted in decreased bacterial susceptibility and increased hospital mortality in patients with severe sepsis or septic shock attributed to Gram-negative bacteremia.
DESIGN: A retrospective cohort study of hospitalized patients (January 2002 to December 2007).
SETTING: Barnes-Jewish Hospital, a 1200-bed urban teaching hospital. PATIENTS: Seven hundred fifty-four consecutive patients with Gram-negative bacteremia complicated by severe sepsis or septic shock.
INTERVENTIONS: Data abstraction from computerized medical records.
MEASUREMENTS AND MAIN RESULTS: Escherichia coli (30.8%), Klebsiella pneumoniae (23.2%), and Pseudomonas aeruginosa (17.6%) were the most common isolates from blood cultures. Three hundred ten patients (41.1%) had recent antibiotic exposure. Cefepime was the most common agent with previous exposure (50.0%) followed by ciprofloxacin (32.6%) and imipenem or meropenem (28.7%). Patients with prior antibiotic exposure had significantly higher rates of resistance to cefepime (29.0% vs. 7.0%), piperacillin/tazobactam (31.9% vs. 11.5%), carbapenems (20.0% vs. 2.5%), ciprofloxacin (39.7% vs. 17.6%), and gentamicin (26.1% vs. 7.9%) (p < .001 for all comparisons). Patients with recent antibiotic exposure had greater inappropriate initial antimicrobial therapy (45.4% vs. 21.2%; p < .001) and hospital mortality (51.3% vs. 34.0%; p < .001) compared with patients without recent antibiotic exposure. Multivariate logistic regression analysis demonstrated that recent antibiotic exposure was independently associated with hospital mortality (adjusted odds ratio, 1.70; 95% confidence interval, 1.41-2.06; p = .005). Other variables independently associated with hospital mortality included use of vasopressors, infection resulting from P. aeruginosa, inappropriate initial antimicrobial therapy, increasing Acute Physiology and Chronic Health Evaluation II scores, and the number of acquired organ failures.
CONCLUSIONS: Recent antibiotic exposure is associated with increased hospital mortality in Gram-negative bacteremia complicated by severe sepsis or septic shock. Clinicians caring for patients with severe sepsis or septic shock should consider recent antibiotic exposure when formulating empiric antimicrobial regimens for suspected Gram-negative bacterial infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21499086     DOI: 10.1097/CCM.0b013e31821b85f4

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  28 in total

Review 1.  [Tarragona strategy--appropriate antibiotic therapy in the ICU].

Authors:  L Engelmann; D V Schmitt
Journal:  Med Klin Intensivmed Notfmed       Date:  2014-03-22       Impact factor: 0.840

2.  Recent Anti-Microbial Exposure Is Associated with More Complications after Elective Surgery.

Authors:  Christopher A Guidry; Puja M Shah; Zachary C Dietch; Nathan R Elwood; Elizabeth D Krebs; J Hunter Mehaffey; Robert G Sawyer
Journal:  Surg Infect (Larchmt)       Date:  2018-06-08       Impact factor: 2.150

3.  Impact of extended-spectrum β-lactamase production on treatment outcomes of acute pyelonephritis caused by escherichia coli in patients without health care-associated risk factors.

Authors:  Sun Hee Park; Su-Mi Choi; Dong-Gun Lee; Sung-Yeon Cho; Hyo-Jin Lee; Jae-Ki Choi; Jung-Hyun Choi; Jin-Hong Yoo
Journal:  Antimicrob Agents Chemother       Date:  2015-01-12       Impact factor: 5.191

4.  In vitro activities of 21 antimicrobial agents alone and in combination with aminoglycosides or fluoroquinolones against extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremia.

Authors:  Min Kyeong Cha; Cheol-In Kang; So Hyun Kim; Sun Young Cho; Young Eun Ha; Yu Mi Wi; Doo Ryeon Chung; Kyong Ran Peck; Jae-Hoon Song
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

5.  Dietary Supplementation With Nonfermentable Fiber Alters the Gut Microbiota and Confers Protection in Murine Models of Sepsis.

Authors:  Michael J Morowitz; Valentina Di Caro; Diana Pang; Jessica Cummings; Brian Firek; Matthew B Rogers; Sarangarajan Ranganathan; Robert S B Clark; Rajesh K Aneja
Journal:  Crit Care Med       Date:  2017-05       Impact factor: 7.598

6.  Optimizing empiric antibiotic therapy in patients with severe β-lactam allergy.

Authors:  Lindsey P Koliscak; James W Johnson; James R Beardsley; David P Miller; John C Williamson; Vera P Luther; Christopher A Ohl
Journal:  Antimicrob Agents Chemother       Date:  2013-09-16       Impact factor: 5.191

Review 7.  Improving the Recognition of, and Response to In-Hospital Sepsis.

Authors:  Peter Chan; Sandra Peake; Rinaldo Bellomo; Daryl Jones
Journal:  Curr Infect Dis Rep       Date:  2016-07       Impact factor: 3.725

8.  Sepsis: a review for the neurohospitalist.

Authors:  Lioudmila V Karnatovskaia; Emir Festic
Journal:  Neurohospitalist       Date:  2012-10

9.  Toll-like receptor stimulation induces nondefensin protein expression and reverses antibiotic-induced gut defense impairment.

Authors:  Ying-Ying Wu; Ching-Mei Hsu; Pei-Hsuan Chen; Chang-Phone Fung; Lee-Wei Chen
Journal:  Infect Immun       Date:  2014-03-04       Impact factor: 3.441

10.  A clinical trial comparing physician prompting with an unprompted automated electronic checklist to reduce empirical antibiotic utilization.

Authors:  Curtis H Weiss; David Dibardino; Jason Rho; Nina Sung; Brett Collander; Richard G Wunderink
Journal:  Crit Care Med       Date:  2013-11       Impact factor: 7.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.